동종 세포 치료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 11.5%로 18억 6,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 선진의료에 대한 요구 증가, 신규 동종세포 치료에 대한 수요 증가, 임상시험 건수 증가, 환자 인구 공헌 증가, 소득 수준의 상승 등에 기인하고 있습니다. 예측기간의 주요 동향으로는 기술의 진보, 파트너십, 대기업간의 제휴, M&A, 신제품의 발매 등을 들 수 있습니다.
만성 질환 증가는 동종 세포 치료 시장의 확대를 촉진할 것으로 예상됩니다. 만성 질환은 장기간의 이환을 특징으로 하며 지속적인 의료가 필요하기 때문에 일상생활에 지장을 주고 생활의 질을 저하시킵니다. 이러한 질병의 확산은 생활 습관의 변화, 유전, 환경 독소 및 오염 물질에 대한 노출로 인한 것입니다. 동종 세포 치료는 건강한 기증자세포를 기능부전에 빠진 수령세포나 조직의 수복, 치환, 조절에 이용함으로써 광범위한 만성질환에 대처하는데 큰 가능성을 갖고 있습니다. 예를 들어 미국 국립생물공학정보센터(NCBI)의 보고서에 따르면 2050년까지 50세 이상에서 하나 이상의 만성 질환을 앓고 있는 사람이 99.5% 증가하고 2020년 7,152만명에서 1억 4,266만명으로 증가할 것이라고 했습니다. 그 결과, 만성 질환 증가가 동종 세포 치료 시장의 성장을 가속하고 있습니다.
동종 세포 치료 분야의 주요 기업은 세포처리 플랫폼 등의 선구적 솔루션에 주력하여 시장에서의 지위를 굳히고 있습니다. 예를 들어, 2024년 3월 스웨덴의 헬스케어 기업인 Getinge사는 영국의 생명공학 기업인 CellRev사와 제휴하여 접착세포 확대(ACE)용 연속세포처리 플랫폼인 Livit ACE를 발표했습니다.이 최첨단 플랫폼은 첨단 자동화 기술과 바이오프로세스 기술을 통합하여 세포 생산의 효율성과 확장성을 크게 향상시킵니다. 주요 특징으로는 높은 순도와 생존력을 보장하는 최고 수준의 세포 분리 및 정제 시스템, 충분한 치료 세포 생성을 위한 강력한 확장 능력, 정밀한 세포 공학을 위한 고급 유전자 변형 도구, 그리고 제품 안전성과 효능을 보장하기 위한 엄격한 품질 관리 프로토콜이 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 동종 세포 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 동종 세포 치료 시장 : 성장률 분석
- 세계의 동종 세포 치료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 동종 세포 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 동종 세포 치료 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 동종 세포 치료 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 줄기세포요법
- 비줄기세포요법
- 세계의 동종 세포 치료 시장 : 치료 영역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 혈액 질환
- 피부질환
- 기타 치료 영역
- 세계의 동종 세포 치료 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 전문 클리닉
- 연구기관
- 세계의 동종 세포 치료 시장 : 줄기세포요법유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 조혈 줄기 세포 요법
- 중간엽 줄기세포요법
- 유도 다능성 줄기세포
- 신경줄기세포요법
- 기타 줄기세포요법
- 세계의 동종 세포 치료 시장 : 비 줄기 세포 치료유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- T세포요법
- 내츄럴 킬러(NK) 세포요법
- 수지상세포요법
- 기타 비 줄기 세포 요법
제7장 지역별/국가별 분석
- 세계의 동종 세포 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 동종 세포 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 동종세포 치료 시장 : 경쟁 구도
- 동종세포 치료 시장 : 기업 프로파일
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
- Poseida Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Fate Therapeutics Inc.
- Fortress Biotech Inc.
- Sorrento Therapeutics Inc.
- Eureka Therapeutics Inc.
- Juno Therapeutics Inc.
- Adaptimmune Therapeutics plc
- Cellectis SA
- TrakCel Ltd.
- Promab Biotechnologies Inc.
- Ziopharm Oncology Inc.
- Allogene Therapeutics Inc.
- Century Therapeutics Inc.
- Autolus Therapeutics plc
- Bellicum Pharmaceuticals Inc.
- Minerva Biotechnologies Corporation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 동종 세포 치료 시장 2029 : 새로운 기회를 제공하는 국가
- 동종 세포 치료 시장 2029 : 새로운 기회를 제공하는 부문
- 동종 세포 치료 시장 2029 : 성장 전략
제36장 부록
SHW
Allogeneic cell therapy involves harvesting cells from a donor to treat a recipient. Its purpose is to replace or repair damaged tissues, modulate immune responses, or address conditions such as cancer, genetic disorders, and autoimmune diseases.
There are two main types of allogeneic cell therapy stem cell therapies and non-stem cell therapies. Stem cell therapies use stem cells to repair or replace damaged tissues or organs, aiming to prevent or treat a range of diseases and conditions. These therapies are applied in various medical fields, including hematological disorders, dermatological disorders, and other therapeutic areas, utilized by hospitals, specialty clinics, and research organizations.
The allogenic cell therapy market research report is one of a series of new reports from The Business Research Company that provides allogenic cell therapy market statistics, including allogenic cell therapy industry global market size, regional shares, competitors with a allogenic cell therapy market share, detailed allogenic cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the allogenic cell therapy industry. This allogenic cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The allogeneic cell therapy market size has grown rapidly in recent years. It will grow from $1.08 billion in 2024 to $1.2 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to an increased focus on tailoring donor cell selection and genetic modifications, increased population, increase in the global burden of chronic diseases, increased awareness, and increase in the number of collaborations for biosimilar development.
The allogeneic cell therapy market size is expected to see rapid growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to the increasing need for advanced medical treatments, growing demand for novel allogeneic cell therapies, rising number of clinical trials, growing patient population contributions, and rising income levels. Major trends in the forecast period include technology advancements, partnerships, big companies collaborating with others, merger and acquisitions, new product launch.
The rise in chronic diseases is expected to propel the expansion of the allogeneic cell therapy market. Chronic illnesses, characterized by prolonged duration and necessitating continual medical care, can impede daily functioning and diminish life quality. These conditions' prevalence stems from altered lifestyle habits, genetic inheritance, and exposure to environmental toxins and pollutants. Allogeneic cell therapy offers substantial promise in addressing a broad spectrum of chronic diseases, utilizing healthy donor cells to repair, substitute, or regulate dysfunctional recipient cells or tissues. For example, a report from the National Center for Biotechnology Information (NCBI) projected a 99.5% increase in individuals aged 50 and above suffering from one or more chronic ailments by 2050, rising from 71.52 million in 2020 to 142.66 million. Consequently, the escalating occurrence of chronic diseases propels the allogeneic cell therapy market's growth.
Key players in the allogeneic cell therapy sector are concentrating on pioneering solutions, such as cell processing platforms, to fortify their market standing. These platforms encompass systems and technologies employed in preparing and manipulating cells for therapeutic purposes, including isolation, purification, expansion, modification, and quality assurance to ensure clinical suitability. For instance, in March 2024, Getinge, a Swedish healthcare entity, collaborated with CellRev, a UK biotech firm, to introduce Livit ACE, a continuous cell processing platform for Adherent Cell Expansion (ACE). This cutting-edge platform integrates advanced automation and bioprocessing technologies, markedly augmenting cell production efficiency and scalability. Notable features include top-tier cell isolation and purification systems ensuring high purity and viability, robust expansion capabilities for generating ample therapeutic cells, advanced genetic modification tools for precise cell engineering, and stringent quality control protocols to ensure product safety and efficacy.
In February 2024, AstraZeneca, a UK-based pharmaceutical company specializing in oncology and rare diseases, acquired Gracell Biotechnologies for an undisclosed amount. This strategic acquisition allows AstraZeneca to enhance its portfolio in oncology and rare diseases by integrating Gracell Biotechnologies' advanced cell therapy capabilities. Gracell's expertise in allogeneic cell therapy could accelerate the development of innovative treatments for challenging cancers and other serious conditions. Gracell Biotechnologies, based in China, is recognized for its pioneering work in cell therapy, aiming to revolutionize the treatment landscape for various cancers and rare diseases.
Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG
North America was the largest region in the allogeneic cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the allogeneic cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The allogeneic cell therapy market includes revenues earned by entities through induced pluripotent stem cell therapy, hematopoietic stem cell transplantation, mesenchymal stem cell (MSC) therapy, induced pluripotent stem cell (IPSC) therapy and chimeric antigen receptor T cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Allogeneic Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on allogeneic cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for allogeneic cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allogeneic cell therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Stem Cell Therapies; Non-Stem Cell Therapies
- 2) By Therapeutic Area: Hematological Disorders; Dermatological Disorders; Other Therapeutic Area
- 3) By End User: Hospitals; Specialty Clinics; Research Organizations
- Subsegments:
- 1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells); Mesenchymal Stem Cell Therapy (MSC-Based Therapies); Induced Pluripotent Stem Cells (iPSC-Based Therapies); Neural Stem Cell Therapy; Other Stem Cell Therapies
- 2) By Non-Stem Cell Therapies: T-cell Therapies; Natural Killer (NK) Cell Therapies; Dendritic Cell Therapies; Other Non-Stem Cell Therapies
- Companies Mentioned: Novartis AG; Bristol Myers Squibb Company; Takeda Pharmaceutical Company Limited; Bluebird Bio Inc.; Poseida Therapeutics Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Allogeneic Cell Therapy Market Characteristics
3. Allogeneic Cell Therapy Market Trends And Strategies
4. Allogeneic Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Allogeneic Cell Therapy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Allogeneic Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Allogeneic Cell Therapy Market Growth Rate Analysis
- 5.4. Global Allogeneic Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Allogeneic Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Allogeneic Cell Therapy Total Addressable Market (TAM)
6. Allogeneic Cell Therapy Market Segmentation
- 6.1. Global Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Stem Cell Therapies
- Non-Stem Cell Therapies
- 6.2. Global Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hematological Disorders
- Dermatological Disorders
- Other Therapeutic Area
- 6.3. Global Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Research Organizations
- 6.4. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hematopoietic Stem Cell Therapy
- Mesenchymal Stem Cell Therapy
- Induced Pluripotent Stem Cells
- Neural Stem Cell Therapy
- Other Stem Cell Therapies
- 6.5. Global Allogeneic Cell Therapy Market, Sub-Segmentation Of Non-Stem Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- T-cell Therapies
- Natural Killer (NK) Cell Therapies
- Dendritic Cell Therapies
- Other Non-Stem Cell Therapies
7. Allogeneic Cell Therapy Market Regional And Country Analysis
- 7.1. Global Allogeneic Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Allogeneic Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Allogeneic Cell Therapy Market
- 8.1. Asia-Pacific Allogeneic Cell Therapy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Allogeneic Cell Therapy Market
- 9.1. China Allogeneic Cell Therapy Market Overview
- 9.2. China Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Allogeneic Cell Therapy Market
- 10.1. India Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Allogeneic Cell Therapy Market
- 11.1. Japan Allogeneic Cell Therapy Market Overview
- 11.2. Japan Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Allogeneic Cell Therapy Market
- 12.1. Australia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Allogeneic Cell Therapy Market
- 13.1. Indonesia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Allogeneic Cell Therapy Market
- 14.1. South Korea Allogeneic Cell Therapy Market Overview
- 14.2. South Korea Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Allogeneic Cell Therapy Market
- 15.1. Western Europe Allogeneic Cell Therapy Market Overview
- 15.2. Western Europe Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Allogeneic Cell Therapy Market
- 16.1. UK Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Allogeneic Cell Therapy Market
- 17.1. Germany Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Allogeneic Cell Therapy Market
- 18.1. France Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Allogeneic Cell Therapy Market
- 19.1. Italy Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Allogeneic Cell Therapy Market
- 20.1. Spain Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Allogeneic Cell Therapy Market
- 21.1. Eastern Europe Allogeneic Cell Therapy Market Overview
- 21.2. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Allogeneic Cell Therapy Market
- 22.1. Russia Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Allogeneic Cell Therapy Market
- 23.1. North America Allogeneic Cell Therapy Market Overview
- 23.2. North America Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Allogeneic Cell Therapy Market
- 24.1. USA Allogeneic Cell Therapy Market Overview
- 24.2. USA Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Allogeneic Cell Therapy Market
- 25.1. Canada Allogeneic Cell Therapy Market Overview
- 25.2. Canada Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Allogeneic Cell Therapy Market
- 26.1. South America Allogeneic Cell Therapy Market Overview
- 26.2. South America Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Allogeneic Cell Therapy Market
- 27.1. Brazil Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Allogeneic Cell Therapy Market
- 28.1. Middle East Allogeneic Cell Therapy Market Overview
- 28.2. Middle East Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Allogeneic Cell Therapy Market
- 29.1. Africa Allogeneic Cell Therapy Market Overview
- 29.2. Africa Allogeneic Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Allogeneic Cell Therapy Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Allogeneic Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Allogeneic Cell Therapy Market Competitive Landscape And Company Profiles
- 30.1. Allogeneic Cell Therapy Market Competitive Landscape
- 30.2. Allogeneic Cell Therapy Market Company Profiles
- 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Poseida Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Allogeneic Cell Therapy Market Other Major And Innovative Companies
- 31.1. Fate Therapeutics Inc.
- 31.2. Fortress Biotech Inc.
- 31.3. Sorrento Therapeutics Inc.
- 31.4. Eureka Therapeutics Inc.
- 31.5. Juno Therapeutics Inc.
- 31.6. Adaptimmune Therapeutics plc
- 31.7. Cellectis SA
- 31.8. TrakCel Ltd.
- 31.9. Promab Biotechnologies Inc.
- 31.10. Ziopharm Oncology Inc.
- 31.11. Allogene Therapeutics Inc.
- 31.12. Century Therapeutics Inc.
- 31.13. Autolus Therapeutics plc
- 31.14. Bellicum Pharmaceuticals Inc.
- 31.15. Minerva Biotechnologies Corporation
32. Global Allogeneic Cell Therapy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Allogeneic Cell Therapy Market
34. Recent Developments In The Allogeneic Cell Therapy Market
35. Allogeneic Cell Therapy Market High Potential Countries, Segments and Strategies
- 35.1 Allogeneic Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Allogeneic Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Allogeneic Cell Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
